Adapting the ACMG/AMP variant classification framework: A perspective from the ClinGen Hemoglobinopathy Variant Curation Expert Panel
Petros Kountouris(Cyprus Institute of Neurology and Genetics), Coralea Stephanou(Agruicultural Research Institute), John S. Waye(University of Toronto), Cornelis L. Harteveld(Leiden University Medical Center), Tamara T. Koopmann(Academic Medical Center), Marina Kleanthous(Cyprus Institute of Neurology and Genetics), Kyriaki Michailidou(University of Cambridge), Joanne Traeger‐Synodinos(National and Kapodistrian University of Athens), Celeste Bento(Hospitais da Universidade de Coimbra), Bin Alwi Zilfalil(Hospital Universiti Sains Malaysia), Hashim Halim‐Fikri(Universiti Sains Malaysia), Carsten W. Lederer(Cyprus Institute of Neurology and Genetics), Landry Nfonsam(Hamilton Regional Laboratory Medicine Program), Irene Fylaktou(National and Kapodistrian University of Athens)
Cited by 38
Related Papers
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Gene for von Recklinghausen Neurofibromatosis Is in the Pericentromeric Region of Chromosome 17
|Science|1987|698
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638